Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection

Archive ouverte

Séror, Claire | Melki, Marie-Thérèse | Subra, Frédéric | Raza, Syed Qasim | Bras, Marlène | Saidi, Héla | Nardacci, Roberta | Voisin, Laurent | Paoletti, Audrey | Law, Fredéric | Martins, Isabelle | Amendola, Alessandra | Abdul-Sater, Ali | Ciccosanti, Fabiola | Delelis, Olivier | Niedergang, Florence | Thierry, Sylvain | Saïd-Sadier, Najwane | Lamaze, Christophe | Métivier, Didier | Estaquier, Jérôme | Fimia, Gian Maria | Falasca, Laura | Casetti, Rita | Modjtahedi, Nazanine | Kanellopoulos, Jean, M. | Mouscadet, Jean-François | Ojcius, David, M. | Piacentini, Mauro | Gougeon, Marie-Lise | Kroemer, Guido | Perfettini, Jean-Luc

Edité par CCSD ; Rockefeller University Press -

International audience. Extracellular adenosine triphosphate (ATP) can activate purinergic receptors of the plasma membrane and modulate multiple cellular functions. We report that ATP is released from HIV-1 target cells through pannexin-1 channels upon interaction between the HIV-1 envelope protein and specific target cell receptors. Extracellular ATP then acts on purinergic receptors, including P2Y2, to activate proline-rich tyrosine kinase 2 (Pyk2) kinase and transient plasma membrane depolarization, which in turn stimulate fusion between Env-expressing membranes and membranes containing CD4 plus appropriate chemokine co-receptors. Inhibition of any of the constituents of this cascade (pannexin-1, ATP, P2Y2, and Pyk2) impairs the replication of HIV-1 mutant viruses that are resistant to conventional antiretroviral agents. Altogether, our results reveal a novel signaling pathway involved in the early steps of HIV-1 infection that may be targeted with new therapeutic approaches.

Consulter en ligne

Suggestions

Du même auteur

SUGT1 controls susceptibility to HIV-1 infection by stabilizing microtubule plus-ends

Archive ouverte | Allouch, Awatef | CCSD

International audience. Understanding the viral-host cell interface during HIV-1 infection is a prerequisite for the development of innovative antiviral therapies. Here we show that the suppressor of G2 allele of sk...

HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry

Archive ouverte | Paoletti, Audrey | CCSD

International audience

Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death

Archive ouverte | Martins, Isabelle | CCSD

International audience. Even though cell death modalities elicited by anticancer chemotherapy and radiotherapy have been extensively studied, the ability of anticancer treatments to induce non-cell-autonomous death ...

Chargement des enrichissements...